STING1 and atherosclerosis: Tetrandrine was found to inhibit the STING/TBK1/NF-κB pathway, reducing inflammation in macrophages attacked by oxidized low-density lipoprotein, and attenuating atherosclerosis in HFD-fed ApoE mice (170).